The research on breast cancer cell has demonstrated that APS can trigger the release of NO and tumor necrosis factor (TNF) from macrophages, possibly by activating of the TLR4-mediated MyD88-dependent signaling pathway, which directly blocks tumor growth [49–51]. This evidence concerns the gene TNF and neoplasm.